Latest Insider Transactions at Cigna Corp (CI)
This section provides a real-time view of insider transactions for Cigna Corp (CI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cigna Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cigna Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 24
2024
|
Phillip Ozuah Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+31.67%
|
-
|
|
Mar 26
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,761
+2.13%
|
$1,078,779
$139.22 P/Share
|
|
Mar 25
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
31,209
-8.23%
|
$11,079,195
$355.17 P/Share
|
|
Mar 25
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,209
+7.6%
|
$4,338,051
$139.22 P/Share
|
|
Mar 22
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,338
-1.79%
|
$2,249,990
$355.11 P/Share
|
|
Mar 22
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,338
+1.76%
|
$880,982
$139.22 P/Share
|
|
Mar 21
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,293
-0.65%
|
$814,015
$355.02 P/Share
|
|
Mar 21
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,293
+0.65%
|
$318,727
$139.22 P/Share
|
|
Mar 14
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,616
+2.14%
|
$1,058,624
$139.22 P/Share
|
|
Mar 13
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
13,761
-0.98%
|
$4,775,067
$347.22 P/Share
|
|
Mar 13
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,761
+3.74%
|
$1,912,779
$139.22 P/Share
|
|
Mar 12
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,238
-0.65%
|
$772,110
$345.0 P/Share
|
|
Mar 12
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,238
+0.65%
|
$311,082
$139.22 P/Share
|
|
Mar 08
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,801
-0.82%
|
$966,345
$345.19 P/Share
|
|
Mar 08
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,801
+0.81%
|
$389,339
$139.22 P/Share
|
|
Mar 07
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,412
-0.35%
|
$834,552
$346.04 P/Share
|
|
Mar 07
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,412
+0.7%
|
$335,268
$139.22 P/Share
|
|
Mar 04
2024
|
Michael W Triplett Special Advisor |
SELL
Open market or private sale
|
Direct |
1,953
-5.68%
|
$648,396
$332.62 P/Share
|
|
Mar 04
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
19,288
-5.36%
|
$6,403,616
$332.62 P/Share
|
|
Mar 04
2024
|
Nicole S Jones Officer |
SELL
Open market or private sale
|
Direct |
4,436
-12.31%
|
$1,472,752
$332.62 P/Share
|
|
Mar 01
2024
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
756
-11.88%
|
$251,748
$333.36 P/Share
|
|
Mar 01
2024
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,240
+27.06%
|
-
|
|
Mar 01
2024
|
Michael W Triplett Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-4.37%
|
$1,079,253
$333.36 P/Share
|
|
Mar 01
2024
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
5,702
+13.15%
|
-
|
|
Mar 01
2024
|
Brian C Evanko Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,435
-6.14%
|
$1,809,855
$333.36 P/Share
|
|
Mar 01
2024
|
Brian C Evanko Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,329
+15.51%
|
-
|
|
Mar 01
2024
|
David J Brailer EVP & Chief Health Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,511
-7.17%
|
$503,163
$333.36 P/Share
|
|
Mar 01
2024
|
David J Brailer EVP & Chief Health Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,780
+20.41%
|
-
|
|
Mar 01
2024
|
David Cordani Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,930
-3.03%
|
$7,635,690
$333.36 P/Share
|
|
Mar 01
2024
|
David Cordani Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
35,946
+8.59%
|
-
|
|
Mar 01
2024
|
Noelle K Eder Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,838
-7.96%
|
$1,278,054
$333.36 P/Share
|
|
Mar 01
2024
|
Noelle K Eder Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,248
+20.1%
|
-
|
|
Mar 01
2024
|
Nicole S Jones Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,971
-6.2%
|
$1,655,343
$333.36 P/Share
|
|
Mar 01
2024
|
Nicole S Jones Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,268
+16.78%
|
-
|
|
Mar 01
2024
|
Eric P Palmer Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,638
-7.07%
|
$2,876,454
$333.36 P/Share
|
|
Mar 01
2024
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,792
+16.89%
|
-
|
|
Feb 28
2024
|
Nicole S Jones Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,657
+7.51%
|
-
|
|
Feb 28
2024
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,127
+9.27%
|
-
|
|
Feb 28
2024
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
1,709
+5.08%
|
-
|
|
Feb 28
2024
|
Noelle K Eder Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,657
+12.51%
|
-
|
|
Feb 28
2024
|
David J Brailer EVP & Chief Health Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,121
+27.91%
|
-
|
|
Feb 28
2024
|
David Cordani Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,927
+2.78%
|
-
|
|
Feb 28
2024
|
Brian C Evanko Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,127
+12.16%
|
-
|
|
Feb 27
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,000
-0.59%
|
$690,000
$345.04 P/Share
|
|
Feb 27
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+0.59%
|
$278,000
$139.22 P/Share
|
|
Feb 26
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,453
-1.01%
|
$3,616,738
$346.28 P/Share
|
|
Feb 26
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,453
+2.92%
|
$1,452,967
$139.22 P/Share
|
|
Feb 23
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,319
-1.84%
|
$2,180,055
$345.24 P/Share
|
|
Feb 23
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,319
+1.81%
|
$878,341
$139.22 P/Share
|
|
Feb 16
2024
|
William J De Laney Iii Director |
SELL
Bona fide gift
|
Direct |
3,376
-16.57%
|
-
|